Literature DB >> 17022876

Human circadian rhythms: physiological and therapeutic relevance of light and melatonin.

Debra J Skene1, Josephine Arendt.   

Abstract

Ocular light plays a key role in human physiology by transmitting time of day information. The production of the pineal gland hormone melatonin is under the control of the light-dark cycle. Its profile of secretion defines biological night and it has been called the 'darkness hormone'. Light mediates a number of non-visual responses, such as phase shifting the internal circadian clock, increasing alertness, heart rate and pupil constriction. Both exogenous melatonin and light, if appropriately timed, can phase shift the human circadian system. These 'chronobiotic' effects of light and melatonin have been used successfully to alleviate and correct circadian rhythm disorders, such as those experienced following travel across time zones, in night shift work and in circadian sleep disorders. The effectiveness of melatonin and light are currently being optimized in terms of time of administration, light intensity, duration and wavelength, and melatonin dose and formulation. The aim of this review is not to replicate information that has been reported in a number of reviews of the human circadian timing system and the role of melatonin and light, but rather to extract findings relevant to the field of clinical biochemistry.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17022876     DOI: 10.1258/000456306778520142

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  40 in total

Review 1.  Chronobiological disorders: current and prevalent conditions.

Authors:  Lia R A Bittencourt; Rogerio Santos-Silva; Marco T de Mello; Monica L Andersen; Sergio Tufik
Journal:  J Occup Rehabil       Date:  2010-03

2.  Sleep disturbances are related to decreased transmission of blue light to the retina caused by lens yellowing.

Authors:  Line Kessel; Galatios Siganos; Torben Jørgensen; Michael Larsen
Journal:  Sleep       Date:  2011-09-01       Impact factor: 5.849

3.  The effects of spectral tuning of evening ambient light on melatonin suppression, alertness and sleep.

Authors:  Shadab A Rahman; Melissa A St Hilaire; Steven W Lockley
Journal:  Physiol Behav       Date:  2017-05-01

Review 4.  Role of circadian neuroendocrine rhythms in the control of behavior and physiology.

Authors:  Henryk F Urbanski
Journal:  Neuroendocrinology       Date:  2011-04-21       Impact factor: 4.914

5.  Influence of rotating shift work on visual reaction time and visual evoked potential.

Authors:  Hemamalini R V; Krishnamurthy N; Saravanan A
Journal:  J Clin Diagn Res       Date:  2014-10-20

6.  Melatonin Modulates Prohibitin and Cytoskeleton in the Retinal Pigment Epithelium.

Authors:  Srinivas R Sripathi; Cameron L Prigge; Beth Elledge; Weilue He; Johnpaul Offor; Diana R Gutsaeva; Wan Jin Jahng
Journal:  Int J Sci Eng Res       Date:  2017-07

7.  Fluorine substituted methoxyphenylalkyl amides as potent melatonin receptor agonists.

Authors:  Andrew Tsotinis; Rodanthi Kompogennitaki; Ioannis Papanastasiou; Peter J Garratt; Alina Bocianowska; David Sugden
Journal:  Medchemcomm       Date:  2019-02-11       Impact factor: 3.597

8.  Altered sleep architecture and higher incidence of subsyndromal depression in low endogenous melatonin secretors.

Authors:  Shadab Ataur Rahman; Shai Marcu; Leonid Kayumov; Colin Michael Shapiro
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-12-18       Impact factor: 5.270

9.  Diurnal variation of melatonin and cortisol is maintained in non-septic intensive care patients.

Authors:  Asko Riutta; Pauli Ylitalo; Seppo Kaukinen
Journal:  Intensive Care Med       Date:  2009-07-04       Impact factor: 17.440

10.  Administration of Melatonin and Metformin Prevents Deleterious Effects of Circadian Disruption and Obesity in Male Rats.

Authors:  Anthony P Thomas; Jonathan Hoang; Kenny Vongbunyong; Andrew Nguyen; Kuntol Rakshit; Aleksey V Matveyenko
Journal:  Endocrinology       Date:  2016-09-21       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.